Sharecare, Inc. Class A Common Stock

SHCR

Market cap $532M

During panel discussion, Sharecare Co-Founder and Executive Chairman Jeff Arnold to highlight company's next-generation, AI-enabled health navigation experience, AskMD During panel discussion, Sharecare Co-Founder and Executive Chairman Jeff Arnold to highlight company's next-generation, AI-enabled health navigation experience, AskMD

Company doubles down on its commitment to transform personal health journey of every American at invitation-only Health Tech Ecosystem event at the White House Company doubles down on its commitment to transform personal health journey of every American at invitation-only Health Tech Ecosystem event at the White House

Newest solution from Sharecare helps life sciences brands uniquely engage, educate, and activate patients, inspired by evidence-based Chronic Disease Self-Management Programs Newest solution from Sharecare helps life sciences brands uniquely engage, educate, and activate patients, inspired by evidence-based Chronic Disease Self-Management Programs

Company earns Gold for its NCQA-accredited health navigation platform for large employers and commercial health plans, immersive medical animation, and doctor-patient communications support Company earns Gold for its NCQA-accredited health navigation platform for large employers and commercial health plans, immersive medical animation, and doctor-patient communications support

NEW YORK, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. ("Sharecare" or "the Company") (NASDAQ:SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SHCR.

NEW YORK, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. ("Sharecare" or "the Company") (NASDAQ:SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SHCR.

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. ("Sharecare" or "the Company") (NASDAQ:SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SHCR.

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. ("Sharecare" or "the Company") (NASDAQ:SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SHCR.

NEW YORK CITY, NY / ACCESS Newswire / June 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. ("Sharecare" or "the Company") (NASDAQ:SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SHCR.

NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. ("Sharecare" or "the Company") (NASDAQ:SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SHCR.